Display options
Share it on

Clin Exp Immunol. 2021 May;204(2):165-166. doi: 10.1111/cei.13597.

Historical and new insights into pathogenesis of type 1 diabetes (2).

Clinical and experimental immunology

F S Wong, T I Tree

Affiliations

  1. Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
  2. Programme of Infection and Immunity, Department of Immunobiology, Faculty of Life Sciences and Medicine, King's College London, Borough Wing, Guy's Hospital, London, UK.

PMID: 33890285 PMCID: PMC8062994 DOI: 10.1111/cei.13597

Abstract

In this second and final part of the collection of articles for the Immunology of Diabetes Society review series on insights into pathogenesis of type 1 diabetes, we present two articles. The first of these covers a debate that took place in the Immunology of Diabetes Society meeting in London 2018, in which five investigators presented a case for specific immune cells/targets to be the 'Achilles Heel of type 1 diabetes'. The second article presents further insights into the generation of post-translationally modified peptides. It focuses upon mechanisms and processes that lead to new potentially autoantigenic targets for CD8

© 2021 British Society for Immunology.

References

  1. Clin Exp Immunol. 2019 Dec;198(3):314-325 - PubMed
  2. Diabetologia. 2021 Jan;64(1):15-25 - PubMed
  3. Clin Exp Immunol. 2021 May;204(2):179-188 - PubMed
  4. Sci Transl Med. 2021 Mar 3;13(583): - PubMed
  5. Clin Exp Immunol. 2019 Dec;198(3):294-305 - PubMed
  6. Clin Exp Immunol. 2019 Dec;198(3):326-340 - PubMed
  7. Clin Exp Immunol. 2019 Dec;198(3):306-313 - PubMed
  8. Front Immunol. 2021 Feb 18;11:624568 - PubMed

Publication Types